METHODS OF PREPARING SUBSTITUTED PYRAZOLOPYRIMIDINES
The present disclosure provides compounds having Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein R1 is defined as set forth in the specification. The present disclosure also provides methods of preparing a compound of Formula (VI):
1 . A compound of Formula I:
or a pharmaceutically acceptable salt thereof;
wherein
R 1 is selected from cyano, —CHO, —CH 2 NR 2 R 3 , and —CH 2 R 4 ;
R 2 is selected from hydrogen, optionally substituted aryl, and optionally substituted heteroaryl;
R 3 is selected from hydrogen, amino, and —NR 5 R 6 ;
R 4 is selected from Formula II and Formula III:
R 5 and R 6 are individually selected from hydrogen and an amine protecting group;
R 7 is selected from optionally substituted aryl and optionally substituted heteroaryl;
R 8 is selected from carbonyl, alkoxy, and sulfonate; and
R 9 is selected from hydroxy, alkoxy, sulfonate, and a leaving group.
2 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein one of R 5 and R 6 is hydrogen and the other of R 5 and R 6 is an amine protecting group selected from t-butyloxycarbonyl (Boc), fluorenylmethoxycarbonyl (Fmoc), benzyloxycarbonyl (Cbz), acetyl, trifluoroacetamide, phthalimide, benzyl, trityl, benzylideneamine, and toluenesulfonate.
3 . The compound of claim 2 , or a pharmaceutically acceptable salt thereof, wherein the amine protecting group is t-butyloxycarbonyl (Boc).
4 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 1 is —CH 2 NR 2 R 3 , R 2 is hydrogen, and R 3 is amino.
5 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 1 is —CH 2 NR 2 R 3 and R 2 is an optionally substituted pyrimidinyl.
6 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 7 has a Formula XIX:
wherein R 12 and R 13 are individually selected from hydrogen, hydroxy, alkyl, alkoxy, and cycloalkyl.
7 . The compound of claim 6 , or a pharmaceutically acceptable salt thereof, wherein R 12 is cyclopropyl and R 13 is methoxy.
8 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the leaving group is selected from trifluoromethanesulfonate, toluenesulfonate, methanesulfonate, and halogen.
9 . The compound of claim 8 , or a pharmaceutically acceptable salt thereof, wherein the leaving group is trifluoromethanesulfonate.
10 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, selected from the group consisting of:
wherein R 9 is a leaving group, and
wherein R 14 is an amine protecting group.
11 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
12 . A compound of Formula IV:
or a pharmaceutically acceptable salt thereof;
wherein
and
R 11 is hydrogen or alkyl.
13 . The compound of claim 12 , or a pharmaceutically acceptable salt thereof, selected from
14 . A process for preparing a compound of Formula VI:
comprising:
reducing a compound of Formula V:
15 . The process of claim 14 , wherein said reducing occurs in the presence of a palladium catalyst and a trialkylsilane.
16 . The process of claim 14 , wherein said reducing occurs in the presence of a palladium catalyst and triethylsilane.
17 . The process of claim 14 , further comprising:
mixing the compound of Formula VI with gentisic acid in a solvent to form a compound of Formula XVIII:
18 . The process of claim 17 , wherein the compound of Formula VI is mixed with gentisic acid in the presence of a solvent.
19 . The process of claim 18 , wherein the solvent is a mixture of isopropanol and heptane.
20 . A process for preparing a compound of Formula Va:
wherein R 9 is a leaving group selected from trifluoromethanesulfonate, toluenesulfonate, methanesulfonate;
comprising:
reacting a compound of Formula VII:
with toluenesulfonic anhydride, toluenesulfonyl chloride, methansulfonic anhydride, methansulfonyl chloride, trifluoromethanesulfonic anhydride, or trifluoromethanesulfonyl chloride to form a compound of Formula Va.
21 . The process of claim 20 , wherein the compound of Formula VII is reacted with trifluoromethanesulfonic anhydride or trifluoromethanesulfonyl chloride.
22 . A process of preparing a compound of Formula VII:
comprising:
reacting a compound of Formula VIII:
or a salt thereof,
with an acid to form a compound of Formula VII,
wherein R 14 is an amine protecting group.
23 . The process of claim 22 , wherein the acid is trifluoroacetic acid.
24 . The process of claim 22 , wherein said reacting occurs in the presence of toluene as a solvent.
25 . The process of claim 22 , wherein said reacting occurs at a temperature of from about 20° C. to about 55° C.
26 . A process of preparing a compound of Formula VIII:
or a salt thereof,
comprising:
coupling a compound of Formula IX:
or a salt thereof,
with (4-cyclopropyl-6-methoxypyrimidin-5-yl)boronic acid to form a compound of Formula VIII,
wherein R 14 is an amine protecting group.
27 . The process of claim 26 , wherein said coupling occurs in the presence of a palladium catalyst.
28 . The process of claim 26 , wherein said coupling occurs in the presence of a solvent selected from 1,4-dioxane, water, and mixtures thereof.
29 . The process of claim 26 , wherein said coupling occurs at a temperature of from about 20° C. to about 65° C.
30 . A process of preparing a compound of Formula IX:
or a salt thereof,
comprising:
reacting a compound of Formula X:
or a salt thereof,
with a 2,4-dichloropyrimidine-5-carboxylate ester to form a compound of Formula IX,
wherein R 14 is an amine protecting group.
31 . The process of claim 30 , wherein the 2,4-dichloropyrimidine-5-carboxylate ester is ethyl 2,4-dichloropyrimidine-5-carboxylate.
32 . The process of claim 30 , wherein the 2,4-dichloropyrimidine-5-carboxylate ester is isopropyl 2,4-dichloropyrimidine-5-carboxylate.
33 . The process of claim 30 , wherein the compound of Formula X is reacted with the 2,4-dichloropyrimidine-5-carboxylate ester in the presence of a base and a solvent.
34 . The process of claim 33 , wherein the base is an amine base, and the solvent is an alcohol solvent.
35 . The process of claim 34 , wherein the amine base is 2,6-lutidine.
36 . The process of claim 34 , wherein the solvent is isopropanol.
37 . The process of any of claims 22-36 , wherein the amine protecting group is t-butyloxycarbonyl (Boc).
38 . A process of preparing a compound of Formula X:
or a salt thereof,
comprising:
reacting a compound of Formula XI:
with tert-butyl carbazate and a reducing agent to form a compound of Formula X.
39 . The process of claim 38 , wherein the compound of Formula XI is reacted with tert-butyl carbazate in the presence of sodium cyanoborohydride.
40 . The process of claim 38 , wherein the compound of Formula XI is reacted with tert-butyl carbazate in the presence of hydrogen and a transition metal catalyst.
41 . A process of preparing a compound of Formula XI:
comprising:
reacting a compound of Formula XII:
with a reducing agent to form a compound of Formula XI.
42 . The process of claim 41 , wherein the reducing agent is diisobutylaluminum hydride.
43 . A process of preparing a compound of Formula XII:
comprising:
reacting a compound of Formula XIII:
with an alkylating agent to form a compound of Formula XII.
44 . The process of claim 43 , wherein the alkylating agent is selected from 2-iodopropane, 2-bromopropane, 2-isopropyl mesylate, and 2-isopropyl tosylate.
45 . The process of claim 43 , wherein the alkylating agent is 2-iodopropane.
46 . A process of preparing a compound of Formula XIV:
comprising:
reacting a compound of Formula XV:
or a salt thereof,
with a compound of Formula XVI:
to form a compound of Formula XIV.
47 . The process of claim 46 , wherein the compound of Formula XV is reacted with the compound of Formula XVI in the presence of a solvent and a base.
48 . The process of claim 47 , wherein the solvent is selected from ethanol, isopropanol, and tetrahydrofuran.
49 . The process of claim 47 , wherein the base is an amine base.
50 . The process of claim 49 , wherein the base is selected from triethylamine and diisopropylethylamine.
51 . The process of claim 46 , wherein the compound of Formula XV is reacted with the compound of Formula XVI at a temperature of from −20° C. to 25° C.
52 . The process of claim 46 , wherein the reaction of the compound of Formula XV with the compound of Formula XVI also forms a compound of Formula XVII.
53 . The process of claim 52 , wherein the compound of Formula XVII forms in an amount of less than 5% AUC as compared to the area of the compound of Formula XIV.
54 . The process of claim 52 , wherein the compound of Formula XIV is isolated containing less than 1%, less than 0.5%, less than 0.25%, or less than 0.15% AUC of the compound of Formula XVII.
55 . The process of claim 46 , further comprising reacting the compound of Formula XIV with a compound of Formula XXI
to obtain a compound of Formula VI
56 . The process of claim 55 , further comprising mixing the compound of Formula VI with gentisic acid in a solvent to form a compound of Formula XVIII:
57 . A compound of Formula XIV
or a salt thereof, prepared by the process of claim 47 .
58 . A compound of Formula XVII:
or a salt thereof.
59 . A compound of Formula XX:
or a salt thereof.
60 . A compound of Formula XXVIII:
or a salt thereof.
61 . A compound of Formula XXVIV:
or a salt thereof.
62 . A compound of Formula XXX:
or a salt thereof.
63 . A process of preparing a compound of Formula XIV:
comprising:
reacting a compound of Formula X:
or a salt thereof,
with a compound of Formula XVI:
to form a compound of Formula XIV;
wherein R 14 is an amine protecting group.
64 . A process of preparing a compound of Formula XXX:
comprising:
reacting a compound of Formula XXVIV
or a salt thereof,
with a compound of Formula XVI:
to form a compound of Formula XXX.
65 . The process of claim 64 , wherein the compound of Formula XXVIV is reacted with the compound of Formula XVI in the presence of a solvent and a base.
66 . The process of claim 65 , wherein the solvent is selected from ethanol, isopropanol, or THF.
67 . The process of claim 65 , wherein the base is an amine base.
68 . The process of claim 67 , wherein the base is selected from triethylamine and diisopropylethylamine.
69 . The process of claim 64 , wherein the reaction is conducted at a temperature of between −20° C. and 25° C.
70 . A process of preparing a compound of Formula XXVIV:
or a salt thereof,
comprising:
reacting a compound of Formula XXVIII
with acid to form a compound of Formula XXVIV or a salt thereof.
71 . The process of claim 70 , wherein the acid is selected from hydrochloric acid (HCl), hydrobromic acid (HBr), methanesulfonic acid, toluenesulfonic acid, trifluoroacetic acid, and trifluoromethanesulfonic acid.
72 . The process of claim 70 , wherein the reaction is conducted at a temperature of between between 0 and 75° C.
73 . A process of preparing a compound of Formula XXVIII:
or a salt thereof,
comprising:
reacting a compound of Formula XXVII:
with tert-butyl carbazate and a reducing agent to form a compound of Formula XXVIII.
74 . The process of claim 73 , wherein the compound of Formula XXVII is reacted with tert-butyl carbazate in the presence of hydrogen and a transition metal catalyst.
75 . The process of claim 64 , further comprising reacting the compound of Formula XXX with a compound of Formula XXI:
to form a compound of Formula XXXI:
76 . The process of claim 75 , further comprising reacting the compound of Formula XXXI with
wherein X is a leaving group and R 15 is an alkyl group;
to form a compound of Formula XXXII:
or a salt thereof.
77 . The process of claim 76 , wherein R 15 is an isopropyl group.
78 . The process of claim 76 , wherein R 15 is a methyl group.